mTOR 抑制剂化学品
CAS 登录号 | 产品名称 | 分子式 |
---|
1009298-09-2 | AZD 8055; [5-[2,4-二((3S)-3-甲基吗啉-4-基)吡啶并[2,3-d]嘧啶-7-基]-2-甲氧基苯基]甲醇 | C25H31N5O4 |
1009298-59-2 | AZD2014; 3-[2,4-双((3S)-3-甲基吗啉-4-基)吡啶并[5,6-e]嘧啶-7-基]-N-甲基苯甲酰胺 | C25H30N6O3 |
1062159-35-6 | WAY 600; 6-(1H-吲哚-5-基)-4-(4-吗啉基)-1-[1-(3-吡啶基甲基)-4-哌啶基]-1H-吡唑并[3,4-d]嘧啶 | C28H30N8O |
1062161-90-3 | WYE-687; N-[4-[4-(4-吗啉基)-1-[1-(3-吡啶甲基)-4-哌啶基]-1H-吡唑并[3,4-d]嘧啶-6-基]苯基]氨基甲酸甲酯 | C28H32N8O3 |
1062169-56-5 | WYE 354; 4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-吗啉基)-1H-吡唑并[3,4-d]嘧啶-1-基]-1-哌啶羧酸甲酯 | C24H29N7O5 |
1092351-67-1 | PP 242; 2-(4-氨基-1-异丙基-1H-吡唑并[3,4-d]嘧啶-3-基)-1H-吲哚-5-醇 | C16H16N6O |
1144068-46-1 | WYE 125132; N-[4-[1-(1,4-二氧杂螺[4.5]癸烷-8-基)-4-(8-氧杂-3-氮杂双环[3.2.1]辛烷-3-基)-1H-吡唑并[3,4-d]嘧啶-6-基]苯基]-N'-甲基脲 | C27H33N7O4 |
1207360-89-1 | GDC-0349; N-Ethyl-N'-[4-[5,6,7,8-四氢-4-[(3S)-3-甲基-4-吗啉基]-7-(3-氧杂环丁基)吡啶并[3,4-d]嘧啶-2-基]苯基]脲 | C24H32N6O3 |
1222998-36-8 | Torin 1; 1-[4-[4-(1-氧代丙基)-1-哌嗪基]-3-(三氟甲基)苯基]-9-(3-喹啉基)苯并[h]-1,6-萘啶-2(1H)-酮 | C35H28F3N5O2 |
1223001-51-1 | Torin 2; 9-(6-氨基-3-吡啶基)-1-[3-(三氟甲基)苯基]苯并[h]-1,6-萘啶-2(1H)-酮 | C24H15F3N4O |
1224844-38-5 | INK-128; 3-(2-氨基-5-苯并恶唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-d]嘧啶-4-胺 | C15H15N7O |
1251156-08-7 | [7-(6-氨基-3-吡啶基)-2,3-二氢-1,4-苯并氧氮杂卓-4(5H)-基][3-氟-2-甲基-4-(甲基磺酰基)苯基]-甲酮 | C23H22FN3O4S |
162635-04-3 | 西罗莫司脂化物; 雷帕霉素 42-[3-羟基-2-(羟甲基)-2-甲基丙酸酯 | C56H87NO16 |
221877-54-9 | 咗他莫司 | C52H79N5O12 |
572924-54-0 | Deforolimus; AP 23573; MK 8669; 42-(二甲基亚膦酰)雷帕霉素 | C53H84NO14P |
914913-88-5 | Palomid 529; 8-(1-羟基乙基)-2-甲氧基-3-[(4-甲氧基苯基)甲氧基]-6H-二苯并[b,d]吡喃-6-酮 | C24H22O6 |
936890-98-1 | OSI-027; 反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-f][1,2,4]三嗪-7-基]环己烷羧酸 | C21H22N6O3 |
938440-64-3 | KU-0063794; 5-[2-[(2R,6S)-2,6-二甲基-4-吗啉基]-4-(4-吗啉基)吡啶并[2,3-d]嘧啶-7-基]-2-甲氧基苯甲醇 | C25H31N5O4 |